The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 6
  • 1
    Theriault, Annie
    Company Director born in April 1977
    Individual (2 offsprings)
    Officer
    2024-11-19 ~ now
    OF - Director → CIF 0
  • 2
    Sturt, Gemma Elizabeth Olivia
    Investment Professional born in March 1997
    Individual (1 offspring)
    Officer
    2024-11-19 ~ now
    OF - Director → CIF 0
  • 3
    Liu, Jian Rui, Dr
    Chief Executive born in November 1992
    Individual (1 offspring)
    Officer
    2020-02-03 ~ now
    OF - Director → CIF 0
  • 4
    Wilson, Bradley
    Company Director born in November 1947
    Individual (1 offspring)
    Officer
    2021-06-30 ~ now
    OF - Director → CIF 0
  • 5
    Halner, Andreas Joseph, Dr
    President & Coo, Oxford Cancer Analytics Ltd born in November 1996
    Individual (1 offspring)
    Officer
    2020-02-03 ~ now
    OF - Director → CIF 0
  • 6
    East, Marcus Delano
    Technologist born in February 1972
    Individual (6 offsprings)
    Officer
    2021-06-30 ~ now
    OF - Director → CIF 0
Ceased 4
  • 1
    Wang, Cheng-zhi
    Chief Scientist And Vice President born in April 1984
    Individual
    Officer
    2021-08-27 ~ 2023-06-27
    OF - Director → CIF 0
  • 2
    Dr Jian Rui Liu
    Born in November 1992
    Individual (1 offspring)
    Person with significant control
    2020-02-03 ~ 2024-11-27
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75%CIF 0
    PE - Right to appoint or remove directorsCIF 0
  • 3
    Qiao, Zhixin
    Senior Vice President Of Megarobo born in September 1978
    Individual (1 offspring)
    Officer
    2023-06-27 ~ 2024-11-19
    OF - Director → CIF 0
  • 4
    Mr Andreas Joseph Halner
    Born in November 1996
    Individual (1 offspring)
    Person with significant control
    2020-02-03 ~ 2024-11-27
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

OXFORD CANCER ANALYTICS LTD

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
86900 - Other Human Health Activities
Brief company account
Property, Plant & Equipment
278,234 GBP2023-12-31
141,074 GBP2023-02-28
Fixed Assets
278,234 GBP2023-12-31
141,074 GBP2023-02-28
Debtors
1,395 GBP2023-12-31
1,901 GBP2023-02-28
Current assets - Investments
991,583 GBP2023-12-31
Cash at bank and in hand
751,725 GBP2023-12-31
2,969,557 GBP2023-02-28
Current Assets
1,744,703 GBP2023-12-31
2,971,458 GBP2023-02-28
Net Current Assets/Liabilities
1,730,018 GBP2023-12-31
2,952,802 GBP2023-02-28
Total Assets Less Current Liabilities
2,008,252 GBP2023-12-31
3,093,876 GBP2023-02-28
Net Assets/Liabilities
2,008,252 GBP2023-12-31
3,093,876 GBP2023-02-28
Equity
Called up share capital
161 GBP2023-12-31
161 GBP2023-02-28
Share premium
4,272,518 GBP2023-12-31
4,272,518 GBP2023-02-28
Retained earnings (accumulated losses)
-2,264,427 GBP2023-12-31
-1,178,803 GBP2023-02-28
Average Number of Employees
112023-03-01 ~ 2023-12-31
92022-03-01 ~ 2023-02-28
Property, Plant & Equipment - Gross Cost
Plant and equipment
361,501 GBP2023-12-31
145,693 GBP2023-02-28
Computers
3,428 GBP2023-12-31
3,428 GBP2023-02-28
Property, Plant & Equipment - Gross Cost
364,929 GBP2023-12-31
149,121 GBP2023-02-28
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
85,473 GBP2023-12-31
7,682 GBP2023-02-28
Computers
1,222 GBP2023-12-31
365 GBP2023-02-28
Property, Plant & Equipment - Accumulated Depreciation & Impairment
86,695 GBP2023-12-31
8,047 GBP2023-02-28
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
77,791 GBP2023-03-01 ~ 2023-12-31
Computers
857 GBP2023-03-01 ~ 2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
78,648 GBP2023-03-01 ~ 2023-12-31
Property, Plant & Equipment
Plant and equipment
276,028 GBP2023-12-31
138,011 GBP2023-02-28
Computers
2,206 GBP2023-12-31
3,063 GBP2023-02-28
Other Debtors
Current
747 GBP2023-12-31
Other Taxation & Social Security Payable
Current
14,673 GBP2023-12-31
18,644 GBP2023-02-28
Amounts owed to directors
Current
12 GBP2023-12-31
12 GBP2023-02-28

  • OXFORD CANCER ANALYTICS LTD
    Info
    Registered number 12437885
    Bioescalator Innovation Building Building 696, Old Road Campus, Roosevelt Drive, Headington, Oxford OX3 7FZ
    Private Limited Company incorporated on 2020-02-03 (5 years 4 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-02
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.